From: The role of optical coherence tomography guidance in scaffold versus stent optimization
 | Univariate | Multivariate | ||
---|---|---|---|---|
 | Odds ratio (95% CI) | p value | Odds ratio (95% CI) | p value |
Stent type (BRS) | 1.74 (1.03–2.94) | 0.038* | 2.35 (1.28–4.31) | 0.006* |
Clinical presentation: | ||||
 CSA | 0.76 (0.48–1.22) | 0.271 | – | – |
 UA | 0.79 (0.42–1.47) | 0.459 | – | – |
 NSTEMI | 2.02 (1.19–3.42) | 0.009* | 1.71 (0.97–3.01) | 0.062 |
 Late/Lysed MI | 1.8 (0.67–4.82) | 0.238 | – | – |
 Primary PCI | 2.51 (1.15–5.46) | 0.02* | 2.55 (1.1–5.9) | 0.028* |
 Silent ischemia | 0.96 (0.49–1.89) | 0.917 | – | – |
Target vessel: | ||||
 LM | 0.52 (0.2–1.34) | 0.177 | 0.6 (0.18–1.93) | 0.397 |
 LAD | 0.87 (0.56–1.37) | 0.57 | – | – |
 LCX | 1.85 (0.96–3.55) | 0.064 | 1.34 (0.64–2.82) | 0.431 |
 RCA | 0.67 (0.41–1.11) | 0.124 | 0.74 (0.41–1.34) | 0.327 |
ACC/AHA B2/ C lesion class | 1.84 (1.1–3.09) | 0.02* | 1.78 (1.02–3.11) | 0.039* |
Bifurcation stenting | 0.59 (0.29–1.2) | 0.15 | 0.52 (0.22–1.21) | 0.131 |
Moderate/severe calcification | 1.88 (1.19–2.95) | 0.006* | 1.99 (1.2–3.3) | 0.029* |
Overlap | 1.64 (1.04–2.6) | 0.03* | 1.39 (0.82–2.33) | 0.214 |
In-stent restenosis | 0.75 (0.39–1.43) | 0.39 | – | – |
CTO | 1.36 (0.44–4.16) | 0.585 | – | – |
Ostial lesion | 1.34 (0.79–2.28) | 0.275 | – | – |
Stent diameter | 1.09 (0.68–1.75) | 0.714 | – | – |